WallStreetZenWallStreetZen

NASDAQ: LAB
Standard Biotools Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LAB past revenue growth

How has LAB's revenue growth performed historically?
Company
8.57%
Industry
0.12%
Market
17.2%
LAB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LAB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LAB's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LAB earnings and revenue history

Current Revenue
$106.3M
Current Earnings
-$74.7M
Current Profit Margin
-70.2%

LAB Return on Equity

Current Company
N/A
Current Industry
-24%
Current Market
188%

Be the first to know when LAB announces earnings.

LAB Return on Assets

Current Company
-21.5%
Current Industry
6.7%
LAB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LAB Return on Capital Employed

Current Company
-32.58%
Current Industry
11.6%
LAB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LAB vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LAB$106.34M-$65.66M-$74.66M-1.20%N/A
FLGT$289.21M-$134.12M-$167.83M+68.41%N/A
CSTL$219.79M-$45.02M-$57.47M+57.35%N/A
OPK$863.50M-$65.62M-$188.86M-2.70%N/A
CDNA$280.32M-$182.19M-$190.28M+29.63%N/A
View Top Diagnostic & Research Stocks

LAB earnings dates

Next earnings date
May 7, 2024

Standard Biotools Earnings & Revenue FAQ

What were LAB's earnings last quarter?

On Invalid Date, Standard Biotools (NASDAQ: LAB) reported Q4 2023 earnings per share (EPS) of -$0.25, up 3.85% year over year. Total Standard Biotools earnings for the quarter were -$19.78 million. In the same quarter last year, Standard Biotools's earnings per share (EPS) was -$0.26.

If you're new to stock investing, here's how to buy Standard Biotools stock.

What was LAB's earnings growth in the past year?

As of Q2 2024, Standard Biotools's earnings has grown year over year. Standard Biotools's earnings in the past year totalled -$74.66 million.

What is LAB's earnings date?

Standard Biotools's earnings date is Invalid Date. Add LAB to your watchlist to be reminded of LAB's next earnings announcement.

What was LAB's revenue last quarter?

On Invalid Date, Standard Biotools (NASDAQ: LAB) reported Q4 2023 revenue of $28.19 million up 4.32% year over year. In the same quarter last year, Standard Biotools's revenue was $27.02 million.

What was LAB's revenue growth in the past year?

As of Q2 2024, Standard Biotools's revenue has grown 8.57% year over year. This is 8.45 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 0.12%. Standard Biotools's revenue in the past year totalled $106.34 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.